Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium animalis subsp. lactis for Peri-implant Mucositis
NCT04187222Phase 3Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jul 2018
- Primary completion
- Aug 2019
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bifidobacterium animalis lactis in peri-implant mucositis (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Bleeding on Probing at 24 weeks. Started Jul 2018; status: completed.
02
Drugs
bifidobacterium animalis lactis
03
Conditions
peri-implant mucositis
Beyond the preview
Go deeper on NCT04187222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04187222.